Receive More Information

We’re a team of award-winning PhD scientists, bioinformaticians, and mass spectrometry technicians on a mission to achieve earlier relapse detection for better prognosis for Multiple Myeloma patients!

A member of our team will respond to your inquiry within one business day

Our Approach

EasyMTM exploits both MS-based protein sequencing and quantification technologies enhanced by machine learning algorithms, to track the M-protein and provide truly personalized monitoring.

Our Team

Home to Canada’s largest privately-owned MS proteomics facility, our team has over two decades of experience in MS-based proteomics and Big Data-driven machine learning data analysis.